About: Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1998 (uk) im September 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1998 (ast) scientific article published on 01 September 1998 (en)
publication date	wds:Q77223100-AFB4BD11-53F5-4EB3-8A9F-6A67B861C2EB
publication date	1998-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q77223100-029DDA07-D6D7-4621-B22C-F6D9973670A2 wds:Q77223100-062A86FA-4389-4269-B9D7-0E4953CFB250 wds:Q77223100-0B30BB44-456C-486C-972D-48EA07B2CD2F wds:Q77223100-0D8F8E7A-34CC-4D41-81B0-B268531740B5 wds:Q77223100-1FADDEC8-1B0B-42CC-96CB-9B77D7BC5321 wds:Q77223100-42D6F4AF-A0CB-49E6-90D1-320498D37A9C wds:Q77223100-5C83C4EE-91B7-4205-A8E5-8F4F0B6A5493 wds:Q77223100-91AC79DF-A798-4BA8-82A1-57A742310AC2 wds:Q77223100-A22E3A24-2DC0-4BE8-8C4A-BB54D03E19F7
author name string	D Bafaloukos E Samantas G Fountzilas N Pavlidis N Tsavaris P Kosmidis A Athanasiadis E Briasoulis D Skarlos
rdfs:label	Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (en) Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (nl)
skos:prefLabel	Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (en) Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (nl)
name	Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (en) Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (nl)
title	wds:Q77223100-A078CEF3-9E1E-404E-B9B0-6EDFAC25DB95
title	Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study (en)
page(s)	wds:Q77223100-7A6F8801-3E26-40D1-9E8A-91B03A2C0EED
page(s)	426-430
instance of	wds:Q77223100-7AFA1488-5075-442A-885B-A496F2167F7C
instance of	scholarly article
main subject	wds:Q77223100-17205BFE-68D6-4C00-9CF4-FC15A002BB29 wds:Q77223100-2BCA55CB-2B12-43BE-87DB-1830EA965392
main subject	wd:Q418817 carboplatin
PubMed ID	wds:Q77223100-C0AD6FDE-39C8-40AD-AEC9-6582B85472B5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9732220
PubMed ID	9732220
published in	wds:Q77223100-FE4F29ED-6F89-4AF9-BDBC-BDF5B4E9D9B1
published in	Oncology
issue	wds:Q77223100-5B1AA7AE-E413-4063-BF07-A45429E43A16
volume	wds:Q77223100-279E4A30-9D32-4634-9181-CDC5982B680F
issue	5
volume	55
DOI	wds:Q77223100-1CF43872-0073-40D0-97E2-ABAD216D9F46
DOI	http://dx.doi.org/10.1159/000011890
DOI	10.1159/000011890
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77223100
is cites work of	Diagnostic and therapeutic management of cancer of an unknown primary Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis A randomized Phase II trial in patients with carcinoma of an unknown primary site Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial Prognostic stratification in UPC: a role for assessing the value of conventional-dose and high-dose chemotherapy for unknown primary carcinoma Evidence-based oncology mitomycin C provides little additional benefit in the treatment of carcinoma of unknown primary site ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site [Palliative chemotherapy and CUP-syndrome: medical intentions versus patients' attitudes in decision making]
is cites work of	wds:Q26824087-AA01D0B1-9E14-4239-8305-F96005EE55E7 wds:Q37080918-67BE8376-FB05-44C9-8DD8-8BD75EFDAFF2 wds:Q31911671-637859DA-0F14-4F84-8992-E227672A0B1E wds:Q79222605-9DD39FDA-E79B-4776-8E8F-D31B0B1F7857 wds:Q33684971-37A2020B-5F83-4B73-B5B9-D7287BAF4BDB wds:Q35212598-CA3164C9-9E2E-49B3-98A3-647E20E1427B wds:Q34539551-4EBC299C-F567-4831-9B5F-51923FF9F3C2 wds:Q36694054-7FA4493A-0D0D-4C43-9957-F69A27E23E3A wds:Q79866738-767CDF9B-6C5D-4933-8792-4A4D54960386

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software